Sustained antiproliferative mechanisms by RB24, a targeted precursor of multiple inhibitors of epidermal growth factor receptor and a DNA alkylating agent in the A431 epidermal carcinoma of the vulva cell line-Reference-Cited by-同舟云学术

Sustained antiproliferative mechanisms by RB24, a targeted precursor of multiple inhibitors of epidermal growth factor receptor and a DNA alkylating agent in the A431 epidermal carcinoma of the vulva cell line

Published:2004-09 Issue:6 Volume:91 Page:1066-1073
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Banerjee R,Rachid Z,Qiu Q,McNamee J P,Tari A M,Jean-Claude B J

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6602098.pdf

Reference47 articles.

1. Baer JC, Freeman AA, Newlands ES, Watson AJ, Rafferty JA, Margison GP (1993) Depletion of O-6-alkylguanine-DNA alkyltransferase correlates with potentiation of Temozolomide and CCNU toxicity in human tumour cells. Br J Cancer 67: 1299–1302

2. Baig GU, Stevens MFG (1987) Antitumor imidazotetrazines. Part 12. Reactions of mitozolomide and its 3-alkyl congeners with oxygen, nitrogen, halogen, and carbon nucleophiles. J Chem Soc Perkin Trans 1: 665–667

3. Banerjee R, Rachid Z, McNamee J, Jean-Claude BJ (2003) Synthesis of a prodrug designed to release multiple inhibitors of the epidermal growth factor receptor (EGFR) tyrosine kinase and an alkylating agent: a novel tumour targeting concept. J Med Chem 46: 5546–5551

4. Bodell JW, Aida T, Berger MS, Rosenblum ML (1985) Repair of O6-(2-chloroethyl)guanine mediates the biological effects of chloroethylnitrosoureas. Environ Health Perspect 62: 119–126

5. Brahimi F, Matheson S, McNamee J, Tari A, Jean-Claude BJ (2002) Inhibition of epidermal growth factor receptor-mediated signaling by ‘combi-triazene’ BJ2000, a new probe for the combi-targeting postulates. J Pharmacol Exp Ther 303: 238–246

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Analysis of the Superior Efficacy of a Dual Epidermal Growth Factor Receptor (EGFR)-DNA-Targeting Combi-Molecule in Comparison with Its Putative Prodrugs 6-Mono-Alkylamino- and 6,6-Dialkylaminoquinazoline in a Human Osteosarcoma Xenograft Model;Cells;2023-03-16

2. Quantitative Analysis of the Potency of Equimolar Two-Drug Combinations and Combi-Molecules Involving Kinase Inhibitors In Vitro: The Concept of Balanced Targeting;International Journal of Molecular Sciences;2021-09-03

3. Design and Mechanism of Action of a New Prototype of Combi-Molecule “Programed” to Release Bioactive Species at a pH Range Akin to That of the Tumor Microenvironment;Pharmaceuticals;2021-02-16

4. Anticancer Triazenes: from Bioprecursors to Hybrid Molecules;Current Pharmaceutical Design;2019-08-16

5. A type I combi-targeting approach for the design of molecules with enhanced potency against BRCA1/2 mutant- and O6-methylguanine-DNA methyltransferase (mgmt)- expressing tumour cells;BMC Cancer;2017-08-11